Non-Biological Complex Drugs

The Science and the Regulatory Landscape

Nonfiction, Health & Well Being, Medical, Specialties, Pharmacy, Science & Nature, Technology, Engineering, Chemical & Biochemical
Cover of the book Non-Biological Complex Drugs by , Springer International Publishing
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart
Author: ISBN: 9783319162416
Publisher: Springer International Publishing Publication: June 24, 2015
Imprint: Springer Language: English
Author:
ISBN: 9783319162416
Publisher: Springer International Publishing
Publication: June 24, 2015
Imprint: Springer
Language: English

The rise of bio- and nano-technology in the last decades has led to the emergence of a new and unique type of medicine known as non-biological complex drugs (NBCDs). This book illustrates the challenges associated with NBCD development, as well as the complexity of assessing the effects of manufacturing changes on innovator and follow-on batches of NBCDs. It also touches upon proven marketing authorization requirements for biosimilars that could be effective in evaluating follow-on NBCDs, including a demonstration of control over the manufacturing process and a need for detailed physico-chemical characterization and (pre)clinical tests.

This book is meant to be used for years to come as a standard reference work for the development of NBCDs. Moreover, this book aims to stimulate discussions and further our thinking to ensure that decisions regarding the approval of complex drugs are made with relevant scientific data on the table.

View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart

The rise of bio- and nano-technology in the last decades has led to the emergence of a new and unique type of medicine known as non-biological complex drugs (NBCDs). This book illustrates the challenges associated with NBCD development, as well as the complexity of assessing the effects of manufacturing changes on innovator and follow-on batches of NBCDs. It also touches upon proven marketing authorization requirements for biosimilars that could be effective in evaluating follow-on NBCDs, including a demonstration of control over the manufacturing process and a need for detailed physico-chemical characterization and (pre)clinical tests.

This book is meant to be used for years to come as a standard reference work for the development of NBCDs. Moreover, this book aims to stimulate discussions and further our thinking to ensure that decisions regarding the approval of complex drugs are made with relevant scientific data on the table.

More books from Springer International Publishing

Cover of the book Corneal Regeneration by
Cover of the book Biomedical and Pharmaceutical Applications of Electrochemistry by
Cover of the book A History of Palliative Care, 1500-1970 by
Cover of the book Number Theory by
Cover of the book Imaging of Soft Tissue Tumors by
Cover of the book Authoritarianism and Resistance in Turkey by
Cover of the book Hans-Georg Gadamer by
Cover of the book Cultural Anatomies of the Heart in Aristotle, Augustine, Aquinas, Calvin, and Harvey by
Cover of the book Mathematical and Numerical Methods for Partial Differential Equations by
Cover of the book Hardy Type Inequalities on Time Scales by
Cover of the book Materials Processing Fundamentals 2018 by
Cover of the book Corporate Social Responsibility and Diversity Management by
Cover of the book Green's Functions by
Cover of the book The Business of Banking by
Cover of the book Landslide Dynamics: ISDR-ICL Landslide Interactive Teaching Tools by
We use our own "cookies" and third party cookies to improve services and to see statistical information. By using this website, you agree to our Privacy Policy